Enterprise Ireland Asia reposted this
Dublin-based medtech start-up CroiValve, which has developed a minimally invasive treatment for a heart condition known as tricuspid regurgitation (TR), has announced the closing of $16m in Series B financing. The new funding round was led by the MedTech & Irrus Syndicates and included participation from all of the company's current investors, including Enterprise Ireland. Learn more RTE: https://rebrand.ly/-CV-
Congratulations to the CroiValve team on securing $16M in Series B financing! 🎉 Your work in developing innovative treatments for tricuspid regurgitation is truly impressive. Great to see Irish medtech making such a positive impact. Wishing you all the best as you continue to transform patient care! 👏🍀
Would love to see even more Irish representation like this at Digital Health Festival 🙌
Congratulations to all the team CroiValve
Fantastic achievement. Super well done. 👍
Well done
Great news Lucy! 😁💪
Amazing as someone who has undergone two open heart surgeries, this is revolutionary! well done!!